RNTX
Rein Therapeutics
RNTX
RNTX
22 hedge funds and large institutions have $5.2M invested in Rein Therapeutics in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
58% less capital invested
Capital invested by funds: $12.3M → $5.2M (-$7.09M)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.47M | |
| 2 | +$728K | |
| 3 | +$174K | |
| 4 |
Renaissance Technologies
New York
|
+$38.5K |
| 5 |
BlackRock
New York
|
+$23.1K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$262K | |
| 3 | -$155K | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$110K |
| 5 |
BAM
Brave Asset Management
Summit,
New Jersey
|
-$32K |